Case Study: Using Stock Valuation Explained to Uncover Investment Opportunities
Stock valuation explained simply: it is the process of finding the gap between what a share of a company is actually worth and what the market is currently charging for it. That gap is where investment returns come from. This case study walks through three real companies where applying a structured valuation framework revealed mispricing that was not obvious from the headlines.
The companies are Apple (AAPL), Berkshire Hathaway B-shares (BRK.B), and Johnson & Johnson (JNJ). Each represents a different valuation archetype: a high-quality compounder, a diversified holding company, and a dividend stalwart. We used the same methodology for all three, the same approach available in the ValueMarkers screener.
Key Takeaways
- Stock valuation compares a company's intrinsic worth to its current market price. The gap between the two is where investment returns come from.
- No single metric tells the whole story. A low P/E can signal cheapness or a deteriorating business. A high P/E can signal quality or speculation. Context determines which.
- ROIC above the cost of capital is the single most reliable indicator of a business worth owning long-term. AAPL's ROIC of 45.1% is exceptional by any standard.
- Berkshire Hathaway B-shares at a P/B of 1.5 carry a credible floor. Buffett has authorized buybacks at P/B below 1.2, establishing a concrete anchor for valuation.
- JNJ at a 3.1% dividend yield and P/E of 14.1 offers the most classical value setup of the three, with identifiable and bounded litigation risk.
- The ValueMarkers VMCI Score weights Value at 35%, Quality at 30%, Integrity at 15%, Growth at 12%, and Risk at 8%, forcing you to evaluate cheapness alongside business quality.
What Stock Valuation Explained Actually Means in Practice
Most investors treat valuation as a single number. They look at the P/E, compare it to the market average, and call a stock cheap or expensive. That approach misses half the work.
Stock valuation explained properly means answering three questions at once. First, what earnings, cash flows, or assets does the business actually generate? Second, what growth rate is the market embedding in the current price? Third, is the business durable enough to justify that growth assumption?
Answer all three and you have a valuation thesis. Skip any one and you have a guess dressed up as analysis.
Case Study 1: Apple (AAPL) at P/E 28.3
Apple trades at a trailing P/E of 28.3 as of April 2026. For a company with a market cap above $3.4 trillion, that sounds expensive. The real question is whether the quality of those earnings justifies the multiple.
AAPL's ROIC sits at 45.1%. That means Apple generates $45.10 in operating profit for every $100 of capital it deploys. The median S&P 500 company generates roughly $10 to $12. Apple is compounding capital at four times the market rate.
| Metric | AAPL | S&P 500 Median |
|---|---|---|
| Trailing P/E | 28.3 | 22.8 |
| ROIC | 45.1% | 11.4% |
| Free Cash Flow Yield | 3.6% | 4.1% |
| Debt-to-Equity | 1.51 | 0.71 |
| 5-Year EPS Growth | 14.2% | 8.4% |
| Dividend Yield | 0.5% | 1.9% |
The P/E premium is real. The ROIC premium is larger. A business compounding at 45% ROIC for a decade does not stay at 28x earnings. Either earnings grow into the multiple or the multiple expands. Historically, AAPL has done both.
The risk: Apple's iPhone segment represents over 50% of revenue. A structural platform shift that bypasses iOS would compress both earnings and the multiple. Valuation without business risk analysis is incomplete.
The verdict: at P/E 28.3 with ROIC of 45.1%, Apple is priced fairly for what it delivers. The opportunity exists if earnings grow above the embedded 10% to 12% annual expectation.
Case Study 2: Berkshire Hathaway B-Shares (BRK.B) at P/B 1.5
Berkshire Hathaway is a valuation case in its own class. It is a holding company, not an operating business, which makes P/E comparisons nearly meaningless. P/B is the right lens here.
BRK.B trades at a price-to-book of 1.5. Buffett has stated publicly that he finds BRK.B repurchase-worthy at P/B below 1.2. That creates a concrete anchor. The current 1.5x is above that floor but not dramatically so.
What sits inside that book value matters. Berkshire's wholly owned businesses, GEICO, BNSF Railroad, Berkshire Hathaway Energy, and a constellation of manufacturing and service companies, generate operating earnings of roughly $37 billion annually. The equity portfolio, led by AAPL, adds another $300+ billion at market value.
The case for BRK.B at P/B 1.5 is not that it is cheap on a snapshot basis. It is that the businesses inside the book value compound at above-market rates, and management allocates capital with a 60-year track record of intelligent reinvestment.
The risk: Berkshire is now so large that it struggles to find acquisitions that move the needle. The succession question is priced into the P/B discount versus intrinsic value.
The verdict: BRK.B at P/B 1.5 is a moderate-conviction position for patient investors. The margin of safety is not exceptional, but the quality and integrity of the business underneath that book value are.
Case Study 3: Johnson & Johnson (JNJ) at 3.1% Dividend Yield
JNJ offers a dividend yield of 3.1% as of April 2026. The company has raised its dividend for over 60 consecutive years. But dividend streaks are not a valuation argument on their own.
The valuation case for JNJ rests on three pillars. First, its pharmaceutical pipeline is real, with oncology and immunology drugs generating multi-billion dollar revenue streams with patent protection extending into the early 2030s. Second, its medical device segment has pricing power in an aging global population. Third, a payout ratio of around 44% means the dividend is comfortably covered.
| Metric | JNJ | Healthcare Sector Median |
|---|---|---|
| Dividend Yield | 3.1% | 1.4% |
| Payout Ratio | 44% | 38% |
| Trailing P/E | 14.1 | 18.7 |
| ROIC | 16.2% | 10.8% |
| 5-Year Revenue Growth | 3.8% | 5.2% |
| Debt-to-Equity | 0.44 | 0.63 |
The P/E at 14.1 looks genuinely cheap relative to the healthcare sector. The market is discounting JNJ for legacy talc litigation risk and slower revenue growth. Both are real concerns. Whether they justify a 25% discount to sector median P/E is the valuation question.
The verdict: JNJ at 3.1% yield and P/E 14.1 offers a margin of safety that the other two cases do not. It is the most classically undervalued of the three, with the caveat that litigation tail risk is not fully quantifiable.
How the VMCI Score Synthesizes All Three Dimensions
The ValueMarkers VMCI Score prevents the tunnel vision that single-metric analysis creates. It weights five pillars: Value (35%), Quality (30%), Integrity (15%), Growth (12%), and Risk (8%).
Running AAPL, BRK.B, and JNJ through the VMCI framework produces three distinct profiles.
AAPL scores high on Quality and Growth but moderate on Value given its P/E premium. BRK.B scores high on Integrity given decades of capital allocation excellence, moderate on Value, and lower on Growth given Berkshire's scale constraints. JNJ scores high on Value and Integrity but moderate on Growth and carries elevated Risk from litigation.
No single winner. Each stock serves a different portfolio role. The point of a composite score is that you stop searching for one number and start building a complete picture.
Putting a Number on Intrinsic Value with DCF Analysis
Discounted cash flow analysis takes future cash flows and discounts them back to present value using a required rate of return. It is the most direct answer to "what is this business actually worth?"
For AAPL, using a 10% discount rate, 12% free cash flow growth for five years, and a 4% terminal growth rate, the intrinsic value range lands between $185 and $220 per share. At $235 as of April 2026, AAPL trades modestly above the midpoint of that range.
For JNJ, using a 9% discount rate, 4% free cash flow growth, and a 3% terminal rate, intrinsic value falls between $160 and $185 per share. At $150, JNJ trades below its DCF floor. That is a positive signal.
The ValueMarkers DCF calculator lets you run these scenarios in under five minutes. Adjust the growth rate, the discount rate, and the terminal multiple, then see how sensitive the intrinsic value estimate is to each assumption. That sensitivity analysis is often more informative than any single-point estimate.
What This Case Study Teaches About Finding Opportunities
The three stocks above illustrate the spectrum of what stock valuation explained looks like in a real portfolio.
AAPL is a quality-first decision. You pay a fair price for an exceptional business, and your return depends on continued earnings growth.
BRK.B is an integrity-first decision. You back proven capital allocation at a modest premium to book, and your return depends on Berkshire finding productive uses for its growing cash pile.
JNJ is a value-first decision. You buy a quality healthcare business at a discount driven by identifiable, bounded risk, and your return depends on litigation resolving without catastrophic outcomes.
The common thread across all three: none of these positions require the market to suddenly re-rate the stock to some target price. Each thesis is grounded in the underlying business generating cash over time. That is stock valuation explained as a discipline, not a prediction.
Further reading: SEC EDGAR · Investopedia
Why how to value a stock Matters
This section anchors the discussion on how to value a stock. The detailed treatment, formula, and worked examples appear in the body of this article above. The points below summarize the most important takeaways for value investors who want to apply how to value a stock in real portfolio decisions. ValueMarkers exposes the underlying data on every covered ticker via the screener and stock profile pages, so the concepts in this article translate directly into actionable filters.
Key inputs for how to value a stock
See the main discussion of how to value a stock in the sections above for the full treatment, including the inputs, the calculation methodology, the typical sector benchmarks, and the most common pitfalls to avoid. The ValueMarkers screener lets value investors filter the full universe of 100,000+ stocks across 73 exchanges using how to value a stock alongside the rest of the 120-indicator composite, with sector percentiles and historical trends shown on every stock profile.
Sector benchmarks for how to value a stock
See the main discussion of how to value a stock in the sections above for the full treatment, including the inputs, the calculation methodology, the typical sector benchmarks, and the most common pitfalls to avoid. The ValueMarkers screener lets value investors filter the full universe of 100,000+ stocks across 73 exchanges using how to value a stock alongside the rest of the 120-indicator composite, with sector percentiles and historical trends shown on every stock profile.
Related ValueMarkers Resources
- Pb Ratio — Glossary entry for Pb Ratio
- Debt To Equity — Glossary entry for Debt To Equity
- Dividend Yield — Dividend Yield is the metric used to how cheaply a stock trades relative to its fundamentals
- What Is A Stock — related ValueMarkers analysis
- Stock Market Basics — related ValueMarkers analysis
- 10 K — related ValueMarkers analysis
Frequently Asked Questions
what happens if the stock market crashes
If the stock market crashes, individual stock prices fall sharply, often by 30% to 50% from peak levels in severe cases. Value investors typically treat crashes as buying opportunities rather than catastrophes, because businesses like AAPL with 45.1% ROIC do not stop generating cash just because their share price drops. The key is having done valuation work in advance so you know what prices represent genuine value.
what time does the stock market open
U.S. stock markets, the NYSE and Nasdaq, open at 9:30 a.m. Eastern Time on weekdays. Pre-market trading is available from 4:00 a.m. Eastern on most brokerages, and after-hours trading runs until 8:00 p.m. Eastern. Earnings releases often happen outside regular hours, which is why after-hours price moves can be significant for valuation-focused investors.
are stock markets closed today
U.S. stock markets close on all federal holidays, including New Year's Day, Martin Luther King Jr. Day, Presidents' Day, Memorial Day, Juneteenth, Independence Day, Labor Day, Thanksgiving, and Christmas. They close early at 1:00 p.m. Eastern on the trading days before Thanksgiving and Christmas. Your brokerage's published holiday calendar is the most reliable source.
what time does the stock market close
U.S. stock markets close at 4:00 p.m. Eastern Time on standard trading days. After-hours trading continues through most brokerages until 8:00 p.m. Eastern. On shortened trading days, such as the day before Thanksgiving, markets close at 1:00 p.m. Eastern. Post-market moves are often where earnings-driven revaluations begin.
when does the stock market open
The NYSE and Nasdaq open at 9:30 a.m. Eastern Time. If you trade international markets, London opens at 8:00 a.m. GMT, Tokyo at 9:00 a.m. JST, and Hong Kong at 9:30 a.m. HKT. The ValueMarkers screener covers 73 global exchanges, so the same valuation framework applies across all of them regardless of time zone.
why is the stock market down today
The stock market falls on any given day for dozens of reasons: macro data releases, Federal Reserve commentary, earnings misses, geopolitical events, or large institutional rebalancing. Short-term market moves rarely reflect changes in business intrinsic value. When AAPL drops 3% on a bad day, its ROIC of 45.1% has not changed. That disconnect between price and value is exactly what stock valuation explained teaches you to identify and act on.
Start building your own valuation framework at the ValueMarkers academy, where P/E, P/B, ROIC, and DCF analysis are covered with real examples and live screener data.
Written by Javier Sanz, Founder of ValueMarkers. Last updated April 2026.
Ready to find your next value investment?
ValueMarkers tracks 120+ fundamental indicators across 100,000+ stocks on 73 global exchanges. Run the methodology above in seconds with our stock screener, or see today's top-ranked names on the leaderboard.
Related tools: DCF Calculator · Methodology · Compare ValueMarkers
Disclaimer: This content is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making investment decisions.